Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > EV / EBITDA (ntm)

Apellis Pharmaceuticals Inc EV / EBITDA (ntm) Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly EV / EBITDA (ntm) from 2019 to 2019. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Apellis Pharmaceuticals Inc Market Cap for the quarter ending June 06, 2018 was $1,231m
  • Apellis Pharmaceuticals Inc Price / Book for the quarter ending June 06, 2018 was 8.60
  • Apellis Pharmaceuticals Inc Enterprise Value for the quarter ending June 06, 2018 was $1,104m
View Chart On Koyfin